Explants of human endometrium were cultured to study the release of matrix metalloproteinases (MMPs). Analysis of conditioned media by zymography revealed latent and active forms of co ,genase (MMP-1, EC 3.4.24.7), 72-kDa gelatinase A (MMP-2, EC 3.4.24.24), and 92-kDa gelatinase B (MMP-9, EC 3.4.24.35). These proteinases were identified by their Mr, their inhibition by tissue inhibitor of metalloproteinases, and the activation of their zymogens by trypsin or aminophenylmer acetate. In the absence of sex hormone, explants released large a ts of enzyme activities, as measured by densitometry of zymogra or in soluble assays. Physiological concentrations of progesterone (10-200 nM) almost totally abolished the release of coilagenase, of total gelatinase activity, and of the active form of gelatinase B and largely inhibited the release of the active form of gelatinase A. These effects, which were antgoz by mifepristone (RU 38486), suggest that progesterone restrains endometrial tissue breakdown by blocking the secretion and activation of MMPs.
The stroma of the human endometrium shows striking structural changes, especially during the second half of the menstrual cycle (1) . If no pregnancy develops, interstitial shrinkage due to extracellular-matrix breakdown occurs and leads to hemorrhagia and mucosal shedding. The mechanisms of endometrial-tissue breakdown initiated by the fall of plasma progesterone and estradiol are still obscure. A major role of lysosomal enzymes (2) is not supported by biochemical evidence (3) , whereas matrix metalloproteinases (MMPs), a family of neutral nonlysosomal enzymes, appear to be plausible agents of the remodeling of the extracellular matrix of the human endometrium (4) .
MMPs share similar structural domains and properties (for review, see ref. 5) , are secreted as zymogens in the extracellular space, are activated by proteolytic cleavage, and are inhibited by the tissue inhibitors of metalloproteinases (TIMPs). A key feature in the regulation of extracellularmatrix degradation seems to be a fine local balance between MMPs, their activators, and their inhibitors. Interstitial collagenase (MMP-1, EC 3.4.24.7) specifically cleaves the fibrillar collagens into one-fourth and three-fourth fragments, which are susceptible to further degradation by other proteases, among which are two other MMPs, gelatinase A (MMP-2, 72 and 65 kDa, EC 3.4.24.24) and gelatinase B (MMP-9, 92 and 84 kDa, EC 3.4.24.35 ). Both enzymes are also able to degrade other substrates present in human endometrium (1) , such as collagen types V and IV. A third subclass of MMPs has a broad spectrum of substrates and comprises stromelysin 1 (MMP-3, EC 3.4.24.17) and matrilysin (MMP-7, EC 3.4.24.23).
We have studied the possible involvement of MMPs in human endometrial remodeling, using a culture system that maintains the tissue in a similar microenvironment as in situ and responds to sex hormones for several days (3) . This system allowed us to demonstrate that the human endometrium secretes collagenase and gelatinases A and B. The secretion and activation of these MMPs were inhibited by physiological concentrations of progesterone, and these effects were antagonized by mifepristone.
MATERIALS AND METHODS
Organ Culture. Specimens were obtained from biopsies for histological dating of the endometrium; these biopsies were done with the approval of the Ethical Committee of the University of Louvain. Samples were collected in ice-cold sterile phosphate-buffered saline, pH 7.4, and processed for organ culture as described (3) . Because calf serum contains gelatinase, this activity was studied only in medium conditioned without calf serum. In procedure 1, explants were adapted to culture for 1-2 days with 5% (vol/vol) charcoaltreated calf serum (GIBCO) and rinsed; the culture was extended for 1-3 days with serum-free medium renewed daily. In procedure 2, serum was omitted from the start ofthe culture, and no effect on tissue viability was noticed. At the end of the culture, wet explants were weighed and either frozen at -800C for biochemical analysis or fixed for morphological evaluation. Thawed explants were solubilized (3), and their protein content was measured with bicinchoninic acid (6) . Conditioned medium was supplemented with 0.05 vol of 1 M Tris buffer, pH 7.5/1% (vol/vol) Triton X-100/0.1 M CaCl2/60 mM NaN3 and kept frozen at -800C until use. Enzyme activities were normalized to the weight or the protein content of the explants. Hormonal Treatments. A "micronized" form of progesterone (mikro 20, from Schering) was dissolved in ethanol. Final concentration was adjusted by measuring progesterone adsorption (7) with [3H]progesterone (70 Ci/mmol, 1 Ci = 37 GBq; Amersham). Mifepristone (RU 38486, from Roussel-Uclaf) was dissolved in ethanol and used at 5 or 10 uM nominal concentration. In procedure 1, control culture medium contained no ethanol, whereas in procedure 2 the medium contained the same concentration of ethanol as progesterone-containing medium, ranging between 0.05% and 0.5%. No difference in tissue viability was detected between these conditions by histological examination or assay (8) of the daily release of lactate dehydrogenase.
Assay of Colagenase. Collagenase activity was determined at 250C with 3H-acetylated collagen in solution (9) . One unit of collagenase is defined as the amount of enzyme that degrades 1 1Lg of soluble collagen per min. Collagenase was Abbreviations: MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinases; APMA, aminophenylmercuric acetate. §To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. optimally activated either by a 2-hr preincubation at 370C with 2 mM 4-aminophenylmercuric acetate (APMA; Aldrich) or by a 2-min preincubation at 250C with 200 nM trypsin (Worthington) followed by a 10-fold excess of soybean trypsin inhibitor (Cooper Biomedical). Inhibition of activated collagenase by endogenous TIMPs was prevented by preincubation of the samples (30 min at 250C) with 2 mM dithiothreitol (10) followed by a 3-fold dilution with 50 mM Tris-HCl buffer, pH 7.5/150 mM NaCl/5 mM CaCl2/NaN3 at 0.2 mg/ml/0.05% (vol/vol) Triton X-100/10 ,M ZnCl2. The partial (=50%o) inhibition of collagenase by 0.7 mM dithiothreitol was reversed by adding 2 mM cystine before activation. This method was shown to completely prevent the total inhibition of endometrial collagenase at 0.6 unit/ml caused by exogenous purified bovine TIMP at 5 units/ml (from Rh6ne-Poulenc Santd, Vitry-sur-Seine, France).
Assays of Gelatinases. Gelatinase activity was measured in a soluble assay with [3H]gelatin (11) either directly or after activation at 25°C with 0.4 mM APMA for 15 min. Under our assay conditions (16-hr incubation at 37°C), the activity was directly proportional to the amount of enzyme up to 50%o substrate degradation. One unit of gelatinase activity is defined as the amount ofenzyme that degrades 1 ,ug ofgelatin per min into 12% ice-cold trichloroacetic acid-soluble fragments.
Latent and active forms of gelatinases A and B were also analyzed by gelatin-substrate zymography (12) . Unreduced samples were preincubated for 30 min at 25°C in the presence of 2% SDS and submitted to SDS/PAGE on 8 or 10%o polyacrylamide (Serva) slab gels copolymerized with gelatin at 0.5 mg/ml (Sigma). SDS was then removed by rinsing with 2.5% Triton X-100, and the gel was incubated for 18 hr at 35°C in 50 mM Tris HCl buffer, pH 7.5/5 mM CaCl2/NaN3 at 0.2 mg/ml/1% (vol/vol) Triton X-100/1 AM ZnCl2, stained with 0.25% (wt/vol) Serva blue G (Serva), destained with 7% (vol/vol) acetic acid, and analyzed by densitometry. An internal standard was run in each slab gel, and the activities were measured in the linear range of the zymographic assay with at least two dilutions of the conditioned medium.
Identification ofMMPs and ofTheir Inhibitors. Endometrial MMPs were compared on gelatin or identically prepared casein (Merck) zymograms with purified human collagenase, gelatinases A and B, and stromelysin (from H. Nagase, University of Kansas Medical Center, Kansas City, KS) in their latent forms and after APMA (1 mM, 60 min at 37°C) or trypsin activation (400 nM, 10 min at 37°C, followed by trypsin inactivation with 2 mM phenylmethanesulfonyl fluoride; Sigma). Inhibition of gelatin degradation was tested with 1 mM 1,10-phenanthroline (Sigma), 2 mM phenylmethanesulfonyl fluoride, 12 ,uM leupeptin (Protein Research Foundation, Osaka), 1 ,M trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E64; Sigma) and bovine TIMP at 50 units/ml. Endogenous TIMPs were detected on 13% polyacrylamidegelatin reverse zymograms, incubated for 24 hr at 37°C in 20 ml of buffer supplemented with 1 ml of APMA-treated (0.4 mM, 2 hr at 25°C) medium conditioned by cultured mouse calvaria.
Statistical Analysis. The nonparametric Wilcoxon twosample test was used to detect significant differences.
RESULTS
Characterization of Endometrial MMPs and Their Inhibitors. Collagenase was identified in conditioned medium by its activity on native trypsin-resistant collagen in solution at 25°C, by the electrophoretic detection of the characteristic one-fourth and three-fourth breakdown fragments of collagen (data not shown), and by its inhibition by 1,10-phenanthroline and bovine TIMP. Collagenase was entirely latent in most conditioned media and could be activated by APMA or trypsin.
Zymographic analysis disclosed four major bands of neutral gelatinolytic activity (Fig. 1A, lane 3) , all inhibited by 1,10-phenanthroline and by bovine TIMP but not inhibited by serine or cysteine proteinase inhibitors. The relative electrophoretic mobilities of these bands were identical to those of human progelatinase B (band 1) or gelatinase B (band 2) and progelatinase A (band 3) or gelatinase A (band 4). Upon activation by APMA Qane 4), the activity of the latent forms (bands 1 and 3) decreased concomitantly with the increase of active forms (bands 2 and 4). Trypsin (lane 8) had a similar effect on progelatinase B but no significant effect on progelatinase A. The activation of both progelatinases frequently generated multiple bands poorly resolved on slab-gel scans. Taken together, these data identify the first band as the latent 92-kDa gelatinase B, and the multiple second bands as its activated forms. Similarly, the third band corresponds to the latent 72-kDa gelatinase A, and the multiple fourth bands correspond to its activated forms.
Concentrated medium revealed additional bands on gelatin and casein (Fig. 1B) zymograms, corresponding respectively to prostromelysin, procollagenase, stromelysin, and collagenase. Reverse zymography (Fig. 1C) zymograms indicated that progesterone inhibited the release of both latent and active forms of collagenase (Fig. 1C ).
Effects of Progesterone Concentration on Release of Colla-
genase and Gelatinase Activities. When progesterone concentration was increased from 0.1 nM to 10 nM (Fig. 3) , the release of collagenase was inhibited by 90z% and that of active gelatinase B was completely inhibited, whereas that of active gelatinase A was only reduced by =50%. On the other hand, total release of gelatinases B and A was inhibited by 50%o when progesterone concentration was increased from 0.1 nM to 100 nM.
Gelatinase activities released in the absence of progesterone varied largely between distinct endometria (Fig. 4) , and no correlation could be found with the time of sampling during the menstrual cycle. Despite this variability, addition of progesterone constantly decreased the release of all forms of gelatinase activities. DISCUSSION This study demonstrates that explants of human endometrial tissue in culture secrete collagenase (MMP-1) and the related gelatinases A (MMP-2) and B (MMP-9). These MMPs were identified by their characteristic Mr, their activation by APMA and/or trypsin, their activities on collagen or gelatin, and their inhibition by 1,10-phenanthroline and TIMP. Stromelysin, TIMP-1, and TIMP-2 were also detected.
When culturedwithout sex steroid, endometrial explants produce 10-100 milliunits ofprocollagenase per day and per mg of tissue. Such elevated activities are in the same range as those produced by explants of human embryonic, but 20-fold higher than human adult, skin (13) . The rate of release of collagenase and gelatinase activities strikingly increases during the first days of culture. The affinity of collagenase for collagen and the presence of TIMPs could explain why no active collagenase and low gelatinase activities were found in the conditioned medium, when assayed with biochemical methods that do not detect TIMP-proteinase complexes. These complexes are dissociated in zymography (5) , but activity comparisons between different bands of the same proteinase and between different proteinases must be interpreted with caution because the influences of the electrophoretic treatments on the zymographic activities are ignored. For example, zymographic activities of the zymogens could be underestimated, owing to partial refolding of the propeptide after removal of SDS.
In spite of these limitations and of the variable activities produced by endometrial explants in the absence of hormone (Fig. 4 ), our results demonstrate that physiological concentrations of progesterone inhibit the production of the three MMPs from the first to the third day of culture. These effects were antagonized. by the progesterone-antagonist mifepristone (RU 38486). The inactivation of endogenous free TIMPs by dithiothreitol did not significantly increase the collagenase activities, thus indicating that the inhibitory effects of progesterone were not primarily due to an increased release of TIMPs. However, preliminary data (Fig. 1C) suggest a stimulatory effect of progesterone on the release of TIMP-1, as already reported on rabbit uterine cervical fibroblasts (14, 15) .
The influence of progesterone concentration on collagenase and on the zymographic activity of proenzyme and active forms of gelatinases A and B (Fig. 3 ) is of great interest because it confirms a trend appearing in Figs. 2 and 4 . In both types of experiments, total collagenase and the active form of gelatinase B are clearly the most inhibited by progesterone, suggesting a prominent role of these two MMPs in endometrial remodeling. Gelatinases A and B have identical in vitro substrate specificities, but their transcriptional control and their activation mechanisms differ. Macrophages and neutrophils constitutively secrete gelatinase B but do not secrete gelatinase A, whereas skin fibroblasts constitutively produce gelatinase A but produce very low amounts of gelatinase B (16) . The regulatory elements found in the 5'-end flanking region of the human gene for collagenase (5) and gelatinase B (17) differ from those found in the gelatinase A promoter (18) .
The transcriptional regulation of collagenase and gelatinase B actuallydiffers from that of gelatinase A in rabbit corneal fibroblasts (19) .
The physiological activators of the zymogens of collagenase and gelatinases A and B are still unknown. Plasmin, kallikrein, and lysosomal cysteine proteinases are potential activators of procollagenase (20) . The marked inhibitory effect of progesterone on the release of the two plasminogen activators (t-PA and u-PA) from endometrial tissue in culture (21) points to the plasminogen activator/plasmin cascade as the most likely activator of endometrial procollagenase. Stromelysin has been implicated in the full activation of procollagenase (22) , in the activation of progelatinase B (23) , and in the degradation of a variety of extracellular matrix proteins (24) . Stromelysin is produced by a mixture of ovine endometrial epithelial and stromal cells in primary culture (25) and was detected in our organ culture system of human endometrium, where its role remains to be examined. Progelatinase A is not activated by any known proteinase (26) , but it can be activated by a fibroblast cell surface activator (27) . Inhibition by progesterone of the production and/or activation of procollagenase has been observed in other tissues or cells: postpartum rat uterine explants (28) and smooth muscle cells in culture (29) , rabbit (14) and guinea pig (30) uterine cervical fibroblasts, and peritoneal macrophages (31) . On the other hand, progesterone had no effect on the production of collagenase by human myometrial smooth-muscle cells (32) . In contrast, synthesis by stromal cells of human endometrium of a membrane metalloproteinase (EC 3.4.24.-11), acting on enkephalins and bioactive peptides, is stimulated by progesterone (33) .
In summary, our data indicate that collagenase and related MMPs participate in the breakdown of the extracellular matrix of the human endometrium. The rapid and striking inhibitory effect of progesterone on the release and activation of several MMPs from endometrial explants in culture supports the hypothesis that progesterone controls the mainte- 
